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Abstract
Due to low fluorine background signal in vivo, 19F is a good marker to study the fate of exog-
enous molecules by magnetic resonance imaging (MRI) using equilibrium nuclear spin
polarization schemes. Since 19F MRI applications require high sensitivity, it can be impor-
tant to assess experimental feasibility during the design stage already by estimating the
minimum detectable fluorine concentration. Here we propose a simple method for the cali-
bration of MRI hardware, providing sensitivity estimates for a given scanner and coil config-
uration. An experimental “calibration factor” to account for variations in coil configuration
and hardware set-up is specified. Once it has been determined in a calibration experiment,
the sensitivity of an experiment or, alternatively, the minimum number of required spins or
the minimum marker concentration can be estimated without the need for a pilot experi-
ment. The definition of this calibration factor is derived based on standard equations for the
sensitivity in magnetic resonance, yet the method is not restricted by the limited validity of
these equations, since additional instrument-dependent factors are implicitly included dur-
ing calibration. The method is demonstrated using MR spectroscopy and imaging experi-
ments with different 19F samples, both paramagnetically and susceptibility broadened, to
approximate a range of realistic environments.
Introduction
19F MRI is an attractive modality for a range of applications including molecular sensing [1,2]
and cell tracking [3–5]. Imaging of inflammation in vivo using perfluorocarbon (PFC) emul-
sions has been particularly promising, allowing visualisation of inflammation in the peripheral
nervous system in rats [6] as well as the immune response during oncolytic virotherapy in a
mouse tumor model [7].
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19F nuclei are intrinsically sensitive due to their high gyromagnetic ratio, and the absence of
a detectable fluorine background signal in vivo offers high specificity. However, the limited
amount of fluorine that can be delivered to a target tissue, and consequently the low signal-to-
noise ratio (SNR) combined with the low SNR efficacy [8]–i.e. the minimum concentration
required to generate a significant SNR within a reasonable imaging time–is the major obstacle
for the wider application of fluorineMRI [9].
In vivo, the quantification of local fluorine concentration can be achieved by comparing the
total signal of a sample with reference standards of known concentration [10], since the fluo-
rine signal is proportional to the number of 19F spins. However, it would be desirable to esti-
mate the potential sensitivity of a 19F MRI set-up even before a pilot experiment. This could be
the case for new fluorine based contrast agents, drugs or molecular 19F sensors during the
experimental design phase, when complex synthesis would be required before any experiment
could be carried out. Enzymatic sensors [11,12] for example rely on the interaction of the fluo-
rine signal with a paramagnetic metal that induces a paramagnetic shift or relaxation. Even
once synthesized, the actual fluorine basedmolecule is often only available in small quantities
and a complete pilot experimentmay not be initially possible.
In order to determine the potential sensitivity of such agents, we propose a method that
allows an estimation of the minimum 19F concentration required to achieve a target SNR in a
19F experiment with a particular setup by performing a calibration using readily available fluo-
rine compounds. The theoretical framework for determining the sensitivity in a MRI experi-
ment is well established by Hoult and Richards [13]. It was further extended to account for
imaging in vivowith additional factors including electrical losses [14], additional noise contri-
butions [15,16], coil design [17] and field strength [18]. Based on these equations we introduce
a calibration factor that is specific for the experimental imaging setup and allows the determi-
nation of the minimum detectable concentration. The physical relevance of this calibration fac-
tor is explained by using textbook equations, yet it is noted that various additional factors are
implicitly accounted for by the experimental calibration with a known compound. An excep-
tion is the dephasing time constant of transverse magnetization,T2, which can vary consider-
ably in different environments. It is shown that T2 for fluorine can be obtained through
extrapolation from the T2 value of 1H.
We will show that this framework provides a way to estimate the sensitivity of a 19F experi-
ment using a cheap, readily available model compound and extrapolate this to another, possi-
bly expensive or valuable 19F compound. The framework we present here is demonstrated for
simple pulse-acquiremagnetic resonance spectroscopy (MRS) and fast low angle shot
(FLASH) imaging, but can also be the basis for extrapolation to other pulse sequences.
Materials and Methods
Experimental factors contributing to sensitivity
Generally, the sensitivity in magnetic resonance (MR) can be divided into separate aspects: the
sample, the instrument hardware, the pulse sequence and the data analysis protocol. Although
recent developments in MRmethodologyhave somewhat blurred the lines between these four
aspects, they can be treated, to a good approximation as multiplicative and can therefore be dis-
cussed independently of each other.
The sample behaviour can be predicted very well, within the high temperature limit, with
the number of spins contributing to the signal as central variable accessible to the experi-
menter. The choices available for the pulse sequence and analysis protocol are manifold and
their influence on the sensitivity can be substantial. This influence can be quantified well using
analytical and numerical simulations tools. Finally, the hardware represents a parameter with a
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large influence on the sensitivity, which is generally only accessible via calibration measure-
ments and cannot be easily modified or changed in most medical applications. To estimate the
concentration of a sample, a one-time hardware calibration is suggested, while simple pulse
sequences and straightforward analysis routines are considered. Effects of more advanced exci-
tation and analysis techniques could be included by taking advantage of the multiplicity of
their influence, but respective procedures are only outlined.
Theoretical SNR
We define the signal-to-noise ratio as the ratio of the peak amplitude of the nuclear magnetic
resonance (NMR) signal divided by the root mean square (rms) noise amplitude. As detailed in
S1 Text, the theoretically achievable SNR,Ψ, in a single pulse nuclear magnetic resonance
experiment can be approximated by
C ¼
cNAnegħ
2Vs
16
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
K2m0Qo30pT2
VcFk3BT3
s
sinðbÞ: ½1
Here, in SI units, c is the concentration in units of mol/m3,NA the Avogadro constant, ne
the number of equivalent fluorine spins per molecule with the same chemical shift, γ the gyro-
magnetic ratio, ħ the reduced Planck constant, Vs the sample volume, kB the Boltzmann con-
stant, T the temperature, T2 the dephasing time constant of transverse magnetization,Vc the
radiofrequency (rf) coil volume, F the pre-amplifier noise figure (which is generally constant
for the frequency range covered by a given nucleus [19]), μ0 the permeability of free space,Q
the quality factor of the detection circuit,ω0 the Larmor frequency of the nuclear spins, and β
the flip angle associated with the excitation pulse. K is a numerical factor introduced by Hoult
and Richards to account for the specific receiving coil geometry [13].
To translate this approach into practice so that a minimum concentration can be easily eval-
uated, we introduce a calibration factor, Λ, which is determined experimentally. Based on our
idealized SNR equation, the calibration factor is defined as
L :¼
ffiffiffiffiffiffiffiffiffi
K2Q
FVc
s
: ½2
The calibration factor has to be determined once for a given hardware and coil configura-
tion in order to correlate the predicted and experimental SNRs. In practice,Λ also includes spe-
cific corrections for set-ups where SNRs differ from the idealized situation given by Eq 1. These
correction factors include the coil geometry dependency of the filling factor [13] and only con-
tribute a constant multiplicative factor for a givenMRI hardware set-up. To simplify further,
all constant terms are combined into a parameter, Π, which is independent of the sample and
can be evaluated without performing an experiment:
P :¼
16
NAgħ
2
ffiffiffiffiffiffiffiffiffiffiffiffiffi
k3BT3
m0po
3
0
s
: ½3
An explicit equation for the threshold fluorinemarker concentration required to achieve a
target SNR is obtained after rearranging Eq 1:
c ¼
P
L
C
neVs
ffiffiffiffiffi
T
2
p
1
sinðbÞ
: ½4
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To account for the resulting SNR following a number NR of identical pulse-acquisitions, Eq
4 must be modified to include an increased SNR, linearly dependent on
ffiffiffiffiffiffi
NR
p
. The longitudinal
relaxation time, T1, and the repetition time, TR, must also be included now to account for the
recovery of the magnetization after each pulse. Combining these three parameters with Eq 4
gives:
c ¼
P
L
C
neVs
ffiffiffiffiffiffiffiffiffiffiffi
NRT2
p SF
1
sinðbÞ
; ½5
where SF is defined as the saturation factor,
SF ¼
1   cosðbÞexpð  TR=T1ÞÞ
ð1   expð  TR=T1ÞÞ
; ½6
introduced to account for incomplete relaxation (SF 1, if TR≳ 5 × T1).
To estimate the rms noise, data points from off-resonant regions of a spectrumor an image
are selected. In principle, a more reliable method would be to repeat an experimentmultiple
times and determine the rms noise from the variation of the signal amplitude. However, in
addition to thermal noise, such a procedure also includes multiplicative noise, which does not
affect the fundamental detection limit as it scales proportionally with the signal and, at low
SNR values, eventually gets overtaken by thermal noise [20]. Hence the selectedmethod pro-
vides not only a simpler, but also a more robust way to estimate detection limits by masking
contributions that become dominant at high SNR values only.
The primary focus on the detection limit and the, potentially simplified, assumption of
white thermal noise also minimizes the necessity to consider more advanced statistical noise
characterization and filtering techniques [21]. The benefit of these methods are scanner and
protocol dependent and may be included by specifying an additional factor for a particular
experimental setting, yet the necessary effort may only be justified if a large number of studies
with similar protocols are conducted using a particular instrument. Similarly, 19F ghosting arte-
facts are not considered using the presented method, but could be incorporated using previ-
ously published methods [22]. These artefacts may considerably affect the reliability of MR
data, yet the effect on the detection limit is small.
Noise and signal loss in magnitude transformed MR data
Many MRI and someMRS experiments use magnitude transformed images and spectra. In our
analysis, we estimate the rms noise from off-resonant regions of magnitude spectra or images
and use a scaling factor of 0.655 to account for the resulting Rician noise distribution whereΨ
≳ 3. For lower Ψ, the scaling factor would need to be readjusted based on the procedure out-
lined by Gudbjartsson et al. [23].
The dominant source of noise is assumed to be thermal, or Johnson noise. In vivo however
physiological noise is significant, as well as the thermal noise generated by the patient or in the
detection circuit [15,16]. This cannot, in general, be specifiedusing a constant correction term,
but experimental quantification is usually straightforward. Hence additional noise can be
incorporated by scaling the noise term according to the added contribution with respect to the
thermal noise level.
Detection limits for MRI
To accommodate imaging experiments, Eq 5 can be adapted to account for a sample’s signal
being spread over the voxels of volume Vv. We must also include a numerical factor specific to
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the sequence of interest, which represents the theoretical signal available during acquisition.
This factor could be greater than one, for example in the case of a multi-spin-echo sequence.
In this example we have chosen one of the common imaging sequences used in fluorine
experiments [3], a FLASH gradient echo sequence [24], whose associated numerical signal fac-
tor is (sin(β)exp(−TE/T2)), which combined with Eq 5 and the other relevant imaging factors
gives:
c ¼
1
0:655
P
L
C
neVv
ffiffiffiffiffiffiffiffiffiffiffiffi
NR T2
p SF
1
sinðbÞe 
TE
T2
; ½7
where TE is the echo time and T2 is the transverse relaxation time. The equation can be adapted
to any sequence, by suitable replacement of the sequence specific factor. Using Eq 7 we can also
express Nv, the minimum number of detectable spins in a voxel required for a sample to
achieve a target SNR:
Nv ¼
1
0:655
PNA
L
C
ffiffiffiffiffiffiffiffiffiffiffi
NR T2
p SF
1
sinðbÞe 
TE
T2
: ½8
Sample preparation
Two solutions were initially prepared: the first contained 58 mM of 3,5bis(trifluoromethyl)-
benzylamine (C1 in Fig 1, Sigma Aldrich, UK) in methanol (Sigma Aldrich, UK); the second
contained 320 mM of perfluoro-tert-butyl alcohol (Sigma Aldrich, UK) in methanol (C2 in Fig
1, Sigma Aldrich, UK). All other solutions were made by dissolving anhydrous powder of tri-
fluoroacetic acid (TFA, C3 in Fig 1) (Sigma Aldrich, UK) in distilledH2O. All solutions con-
taining C3 were made from 1 M stock solutions (compound concentration) and diluted in
H2O.
A line broadening effect on a compound’s linewidth is likely to occur in vivo, where para-
magnetic species or changing magnetic susceptibility affect fluorinemolecules’ linewidth. In
our experiments we sought to replicate such possible line broadening to verify our method’s
robustness in such cases. To induce line broadening by paramagnetic relaxation, a gadolinium
based contrast agent, gadobenate dimeglumine (MultiHance, Bracco Imaging, SpA, Milan,
Italy) was added to C3. To induce susceptibility broadening, a C3 solution was placed in a
Fig 1. Chemical structures of compounds with variable number of fluorine spins per molecule.
Compound C1 (3,5-bis(trifluoromethyl)benzylamine), six fluorine spins; C2 (perfluoro-tert-butyl alcohol), nine
fluorine spins; C3 (Trifluoroacetic acid), three fluorine spins.
doi:10.1371/journal.pone.0163704.g001
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porous medium that consisted of 0.5 mm diameter solid glass beads (BioSpec Products, Bar-
tlesville, OK). The solution volume fraction in glass beads was derived from the packing vol-
ume of the glass beads in the NMR tube, obtained experimentally by comparing liquid volumes
between an empty tube and a tube containing the glass beads (relative volume of glass beads:
60 ± 10%, compared with an ideal packing volume of 74%) [25].
19F and 1H NMR and MRI experiments
All experiments were performed on a 9.4 T vertical bore Bruker Avance III microimaging sys-
tem (Bruker Corporation, Billerica, USA) with a 25 mm volume coil tuned to the fluorine reso-
nance frequency of 376.5 MHz. Thin walled 5 mmNMR tubes containing 1 mL of each sample
were used in all measurements. Single pulse experiments were used to measure 19F spectro-
scopic SNRs, where the pulse power and duration were calibrated manually. 19F images were
acquired with a fast low angle shot (FLASH) sequence (echo time TE = 1.27 ms; TR = 20 s,
matrix size = 32 x 32; field of view (FOV) = 12 x 12 mm2; slice thickness = 40 mm; flip
angle = 90°, Gaussian pulse, bandwidth BW = 50 kHz). 1H T2 images were acquired with a
multi-gradient echo (MGE) sequence (NR = 32, TR = 3 s, matrix size = 32 x 32, FOV = 12 x 12
mm2, slice thickness = 40 mm, with 12 echo times ranging from 1.98 to 14 ms).
To test the approach in a biological system, we also performed an experiment assessing the
signal of the blood substitute Perftoran (OJSC SPF “Perftoran”, Russia, C22F41N), in an excised
rat lung and heart. This ex vivo setup was previously used to develop 129Xe imaging techniques
[26], but was here used to acquire the 19F spectrumof Perftoran in the lung vasculature and
heart (estimated at a volume of 1.6 ml). Prior to the experiment, a 1 ml Perftoran sample served
as the validation standard to determine the gauge factor. The acquisition was made using a sim-
ple pulse-FID sequence with 512 and 128 signal averages, and total experiment durations of 43
min and 2 min for the standard and the lung samples respectively.
Data processing
SNRs were determined in the images by dividing the average amplitude evaluated from the
region of interest (ROI) containing fluorine signal by the average rms amplitude determined
from a region containing noise only, using Paravision 5.1 scanner software (Bruker BioSpin
GmbH, Ettlingen, Germany). Spectra were processed using Matlab (The Mathworks Inc.,
Natick, MA). The SNR was optimized according to the matched filter condition by applying a
line broadening factor equal to the linewidth at full width half maximum (FWHM) [27]. T
2
was evaluated according to T
2
¼ ðpDnÞ
  1, where Δν is the linewidth in Hz at FWHM. Images
were zero-filled to a 64 x 64 matrix and a sine squared window functionwas applied. In the
porous medium experiment with compound C3, a T
2
measurement was additionally deter-
mined at the ROI of MGE images using scanner software.
Results
Effect of line broadening on 19F spectra
Spectral linewidths were found to be similar for different fluorine concentrations without the
addition of a line broadening species, as shown in Fig 2A. The effect of paramagnetic broaden-
ing through addition of gadolinium on the line shape of C3 (TFA) in different concentrations
is shown in Fig 2B. At the lowest TFA concentration (100 mM), the addition of Gd increased
the linewidth seven-fold from 7 Hz to 50 Hz (Table 1). Susceptibility broadening, when
TFA was added to a porous glass medium, increased spectral lines to a linewidth of 419 Hz
(Table 2).
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Determining the 19F linewidth
As it might be difficult to determine the spatially resolved 19F linewidth in vivo directly due to
the generally low SNR in fluorineMRI, we evaluated whether 19F linewidths can be obtained
from 1H T2 intensity fittedMGE images [28]. For the glass bead sample (solution C3 at 424
mM concentration with glass beads in Fig 3B) a fairly uniform value of T
2
= 0.72 ± 0.21 ms for
1H was found. Generally, T
2
/ g  1 if one assumes a static distribution of the molecules within
the susceptibility-inducedmagnetic field gradients as the dominating cause for line broaden-
ing. From that we determined a 19F relaxation time of T
2
= 0.77 ms corresponding to a fluorine
linewidth of Δν = 417 Hz. By comparison, the direct measurement of the fluorine linewidth
yielded Δν = 419 Hz or T
2
= 0.77 ms (Table 2).
Calibration factor
We sought to determine if the calibration factor was approximately constant for a range of
solutions and in the presence of field inhomogeneities.ΛS was calculated from Eq 7, with
SNRs estimated from 19F MR spectroscopy (Table 3). Across all solutions, the calibration
factor was found to remain within a range of 3.9 x 104 m1.5 to 5.5 x 104 m1.5 despite different
chemical structures and an increase in linewidth by up to two orders of magnitude in the
presence of field inhomogeneities or due to faster relaxation induced by a paramagnetic agent
(Fig 2).
Fig 2. 19F spectra with varying fluorine concentration and paramagnetic broadening. (A) Spectra of 1000 mM (i) and 100 mM (ii)
concentrations of C3. The magnified section shows the scaled noise section. (B) Spectra of C3 (900 mM) with varying concentrations of
gadolinium added. The origin of the spectra (0 Hz) in both (A) and (B) corresponds to a laboratory frame of reference on-resonance with
the main signal.
doi:10.1371/journal.pone.0163704.g002
Table 1. Calibration factor under paramagnetic broadening.
Concentration Δν [Hz] T2* [ms] MRSΨ MRIΨ ΛS × 104m1.5 ΛI × 104m1.5
100 49.6 6.4 266 ± 24 37 ± 4 7.9 ± 1.7 5.9 ± 0.5
600 29.5 10.8 1888 ± 170 240 ± 65 7.1 ± 1.4 5.0 ± 0.4
1000 29.3 10.9 2667 ± 240 391 ± 109 6.0 ± 1.1 4.9 ± 0.5
Calibration factors derived from experimental SNR data from MR spectroscopy, ΛS, and imaging, ΛI, for compound C3 (1000 mM, 600 mM and 100 mM)
with paramagnetic broadening through a 50 mM gadolinium. The linewidth is the spectral FWHM.
doi:10.1371/journal.pone.0163704.t001
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Lowest detectable fluorine concentration
The minimum fluorine concentration detectable for C3 was determined by linear extrapolation
of the relationship between SNR and fluorine concentration, based on a method by previous
fluorine quantification studies [3,29], using a minimum detectable SNR of Ψmin = 3.5 (Fig 4).
The SNR detection threshold was chosen according to previous studies, which have used SNR
values of 3 [30,31] and 3.5 [3]. The SNR was determined from experiment over a range of con-
centrations of TFA as well as from calculations using Eq 7 with calibration factor Λ =
(4.2 ± 1.1) × 104 m1.5, the average of the calibration factors reported in Table 3. As expected,
both calculated and experimental SNRs showed linear dependence on TFA concentration (r2 =
0.99). From extrapolation, the detectable threshold concentration was found to be 0.947 mM
for experimental and 0.948 mM for calculated data. This was experimentally verified by mea-
suring the SNR from a 0.4 mM and 1 mMC3 sample (S2 and S3 Figs); 1mM produced an SNR
around the minimum detectable limit (Ψmin = 3.5), and the 0.4 M sample was found to be
below this limit.
Comparing spectroscopy and imaging
To determine whether the calibration factor would differ if determined fromMRI rather than
spectroscopic experiments, we performed the experiments in the presence of imaging gradi-
ents. The experimental imaging SNR values fromMRI and MRS experiments were compared
Table 2. Calibration factor under susceptibility broadening.
Concentration Δν [Hz] T2* [ms] MRSΨ MRIΨ ΛS × 104m1.5 ΛI × 104m1.5
212 396 0.80 162 ± 16 13 ± 3 6.2 ± 1.6 7.5 ± 2.1
424 419 0.76 342 ± 31 28 ± 6 6.8 ± 1.7 7.5 ± 1.9
Calibration factors derived from experimental SNR data acquired with MR spectroscopy, ΛS, and imaging, ΛI, for C3 (424 mM and 212 mM) with
susceptibility broadening through a glass bead medium.
doi:10.1371/journal.pone.0163704.t002
Fig 3. Paramagnetic and susceptibility broadening effect on 19F MRI. (A) 19F images of C3 (1000 mM, 600 mM, 100 mM) with 50
mM gadolinium added to induce paramagnetic line broadening. Images were acquired with a gradient echo FLASH sequence, TE = 1.3
ms, TR adapted to allow full relaxation, matrix size = 64 × 64, FOV = 1.2 × 1.2 cm2, NR = 1, and slice thickness = 4 cm. (B) 19F image
intensity plots for C3 (424 mM and 212 mM) in a glass bead medium (sketch) inducing susceptibility line broadening.
doi:10.1371/journal.pone.0163704.g003
Detection Limits for 19F MRI
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for the samples containing compound C3. The calibration factors in paramagnetically broad-
ened samples were Λ = (5.3 ± 0.8) x 104 m1.5 whenmeasured by MRI and Λ = (7.0 ± 2.5) x 104
m1.5 whenmeasured by MRS (average over all TFA concentrations measured, Table 1). With
susceptibility broadening, the MRI derived calibration factor was Λ = (7.5 ± 2.8) x 104 m1.5, as
opposed to Λ = (6.5 ± 2.3) x 104 m1.5 whenmeasured by MRS (average over both TFA concen-
trations measured).
Finally, we aimed to test if the theoretical estimation also holds in a biological context (S4
Fig). We therefore measured the spectrum from a blood replacement, the perfluorocarbon
based Perftoran, within the vasculature of an excised rat lung. We compared the SNR from the
lung with the predicted SNR based on an in vitro Perftoran sample. The difference between
predicted and measured SNR in this case was 2%, although greater differences will be expected
in vivo, or when comparing different molecules.
Discussion
In this work, we sought to evaluate the minimum detectable fluorine concentration for a target
SNR under a range of conditions that affect the fluorine signal without performing an individ-
ual pilot study. A calibration factor was defined that characterizes the specific hardware config-
uration, including the radiofrequency rf coil and the scanner itself.
It was shown that the calibration factor remained constant for a range of samples with dif-
ferent chemical structures and fluorine concentrations without substantial line broadening, as
shown for the gadolinium free data in Table 3.
Even in the presence of inhomogeneous broadening the calibration factor was largely inde-
pendent of the measurement technique (spectroscopy or imaging), with calibration factor val-
ues for bothMRS and MRI found to be within error for the majority of data presented in
Tables 1 and 2. Therefore the approach proposed here allows for the use of spectroscopicmea-
surements with model compounds to predict the feasibility of planned imaging and spatially
localised spectroscopic 19F experiments. Also, consistent with previous studies [32], the calibra-
tion factor only weakly depended on the window function (exponential decay in spectroscopy,
sine squared window function for imaging). The exact choice of the line broadening parameter
had a minor effect on the calibration factor, as illustrated in S1 Fig, since the SNR is inversely
proportional to the square root of the linewidth and therefore quite robust over a range of
Table 3. SNR and calibration factors.
Sample ne Concentration [mM] Gd [mM] Δν [Hz] Ψ Λ × 104m1.5
C1 6 58 0 3.6 700 ± 63 4.6 ± 0.6
C2 9 322 0 3.0 5524 ± 497 4.1 ± 0.5
C3 3 100 0 8.2 363 ± 31 4.3 ± 0.6
3 200 0 7.1 723 ± 63 4.0 ± 0.5
3 400 0 7.2 1499 ± 139 4.2 ± 0.4
3 600 0 7.0 2152 ± 196 4.0 ± 0.4
3 800 0 7.3 2983 ± 274 4.2 ± 0.4
3 1000 0 7.5 3698 ± 348 4.2 ± 0.3
C3 3 900 0 7 2418 ± 270 3.9 ± 0.5
3 900 50 36 1450 ± 143 4.3 ± 0.5
3 900 500 339 666 ± 67 5.5 ± 0.7
Standard deviations in calibration factor calculations were evaluated from six independent measurements after sample repositioning for each
measurement.
doi:10.1371/journal.pone.0163704.t003
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broadening values. Furthermore, the calibration factor varied by less than a factor of two when
comparing strongly broadened and high resolution data, which is manageable considering the
two orders of magnitude difference in linewidth of the sample environments. This factor of
two provides an estimate for the accuracy of the predictions achievable with this technique for
the different conditions typically encountered in vivo.
While the proposed approach is simple to implement, some experimental precautions need
to be considered to ensure an accurate estimate of the minimum detectable fluorine concentra-
tion. The dwell time, Δt, between data points should be much smaller than T
2
, otherwise addi-
tional systematic errors are introduced due to numerical inaccuracies and possibly filtering out
of signal contributions. As long as this condition is fulfilled, the influence of the receiver band-
width is small. The choice of acquisition coil, e.g. solenoidal or surface coils, will impact on the
calibration factor. It may be difficult to estimate the filling factor and coil volume accurately.
For coils with a homogeneous rf field, B1, across the sample volume, this is not an issue since
the respective term is factored into Λ and therefore experimentally characterizedwhenΛ is
determined. For surface coils and in particular for sensitivity encoding (SENSE) [33], some
Fig 4. Minimum detectable concentrations in fluorine MRS. Experimental (solid squares) and calculated
SNRs (open circles) vs. concentration for compound C3. The calculated SNR was obtained from an average
calibration factor using Eq 7. Lines of best fit were extrapolated to determine a minimum detectable concentration
assuming a minimum required SNR of 3.5. The fitting of the experimental and derived data resulted in a minimum
detectable limit of 0.947 mM and 0.948 mM respectively.
doi:10.1371/journal.pone.0163704.g004
Detection Limits for 19F MRI
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form of B1 correction is necessary [34]. As a simple approximation, the principle of reciprocity
[13] could be employed by determiningΛ at the location with maximum rf field strength,
B1max, and scale the threshold concentration by a factor B1max/B1(r), where r is the location of
interest. For SENSE acquisitions, the hardware dependant signal enhancement is included in Λ
while pulse sequence or sampling dependant sensitivity factors need to be considered
separately.
In general, pulse sequences contribute another factor to the SNR that is largely hardware
independent. This factor could be estimated using an analytic expression, as has been done for
our FLASH sequence in comparison to the standard single pulse experiment. Alternatively, it is
possible to determine such a factor numerically or experimentally. For the latter, a reference
scan on a different scanner or spectrometer would be sufficient. Ideally, the reference substance
should show comparable relaxation times and linewidths as the compound of interest, and for
minimal errors, the reference scan should be performedwith similar acquisition parameters as
the minimum number of detectable spins calibration experiment.
In our theoretical method we have excluded any temperature dependencies, since our sam-
ples were measured in identical conditions in a temperature controlled environment. However,
the SNR is proportional to T−1.5 (Eq 1), where a factor of T−1 is contributed by the sample mag-
netization and a factor T−1/2 is caused by thermal noise. A fluorinated compound administered
in vivo could result in a SNR decrease of up to 5% compared to a room temperature measure-
ment if coil and sample are independently controlled. By heating the reference sample used for
the calibration experiment to the temperature of the environment of the desired fluorine exper-
iment, which is within a narrow range for in vivo studies, such a systematic error could be
avoided. If the coil is kept at a constant operating temperature, which could be considerably
different from the sample temperature, the temperature difference is absorbed by the calibra-
tion factor, hence no systematic error would be expected either.
For in vivo applications, Q factor changes may be considerable due to the substantial coil
loading, but this may be circumvented by using calibration standards that have Q factors simi-
lar to those typically used in MRI scans. For example, a Q factor of 89 was obtained using a
CuSO4 phantom in a solenoid coil while a Q factor of 84 was measured when this coil was
loaded in a pre-clinical study at 3 T [35]. Due to the square root dependence of theQ value in
Eq 2, typical differences observed for theQ factor of the loaded resonator, QL, will only have a
minor impact on predictions of the minimum concentration. In principle, ifQL and the quality
factor of an unloaded or empty coil,QE, are known, they can be used to modify Eq 1 [36]:
C ¼
cNAnegħ
2Vs
16
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
QEK2m0o30pT2
VcFk3BT3
s ffiffiffiffiffiffi
QL
QE
s
sinðbÞ ½9
As stated above, in vivo thermal noise should also be accounted for in our approach, since
the SNR would be overestimated even when similarQ factors are exhibited for a subject com-
pared to a test sample. Ideally, the noise is determined from an in vivo SNR experiment, from
which the thermal noise contribution could be subsumed into the equations as a constant addi-
tional factor.
Quantification of fluorine content in vitro is important to extrapolate to labelled cell num-
bers in vivo, and our proposedmethod could be used to complement this approach. Several
studies already calculate a minimum detectable fluorine signal, for example, to convert the
fluorine signal of known concentrations to an equivalent number of PFC labelled cells [37]. In
certain situations interaction between the fluorine label and host cell can produce shortened T2
values, leading to under-estimation of the number of labelled cells [38]. With our proposed
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model, expected and actual fluorine content could be compared to infer underlying biological
processes causing a signal reduction, e.g. cell division.
Although demonstrated specifically for 19F experiments, the presented approach is not
limited to this nucleus. Providing independent calibrations are performed for different nuclei
on a given set-up, our methodmay be used to predict expected SNRs and minimum detectable
concentrations for any nuclei. However, in cases where the line shape of an X-nucleus is
not dominated by susceptibility-inducedmagnetic field gradients, estimation using a 1H mea-
surement may not be appropriate and the linewidth or T2 value should be experimentally
verified.
Conclusion
We presented a simple approach that allows for the prediction of minimum detectable fluorine
concentrations in 19F MRI experiments. It was demonstrated for a range of experimental con-
ditions that a calibration factor, specific for a givenMRS or MRI hardware configuration, can
be determined once and then be used to estimate the feasibility of a planned 19F MR study. The
method provides a framework for the sensitivity estimation of 19F experiments and may be
most useful during the design of novel fluorine based contrast agents.
Supporting Information
S1 Fig. Effect of line broadening (LB) on the SNR. (A) Line broadening with an exponentially
decaying window function corresponding to a linewidth of 25 Hz and 50 Hz applied to a sam-
ple spectrumof gadolinium doped sample C3, compared with the original spectrum. (B) The
optimal line broadening factor was 50 Hz, corresponding to 100% relative LB to FWHM. The
SNR and FWHM values follow the expected relation SNR/ T
2
0:5 / FWHM  0:5 (Eq 1).
(EPS)
S2 Fig. Representative 1HMGE image used to calculateT2. A proton image from a MGE
scan is shown, (TE = 1.98 ms), which was part of a series of images with different echo times
used to obtain a T2 value for comparison with spectralT2 (12 echo images, 1 ms spacing).
(EPS)
S3 Fig. Detection limits at low fluorine SNR regimes. Spectra showing the signal from a 1
mM and 0.4 mM TFA (C3) sample. An SNR of 5.8 was measured for the 1 mM sample,
although the linewidthwas 5.1 Hz rather than between 7 and 8 Hz used for the line of best fit.
Accounting for this in Eq 5 gives an SNR of 3.8, close to the predicted 3.5. For the 0.4 mM sam-
ple, 8 averages were needed to obtain a signal, showing a single scan SNR of 1.7, i.e. below the
stated detection limit.
(EPS)
S4 Fig. A complex fluorine signal from the lung vasculature.To demonstrate the application
of the approach, we estimated the SNR from the synthetic blood Perftoran, which carries 41
fluorine atoms and a complex line shape, in the vasculature of an excised rat lung. To estimate
the gauge factor, a standard spectrumof Perftoran in a 1 ml test tube was measured. The areas
in the spectra from which noise and the signal were estimated, are indicated. The fluorine sig-
nal from the lung vasculature is here magnified by a factor of 20.
(EPS)
S1 Text. Derivation of Theoretical SNR and description of relaxometry.
(DOCX)
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